Market Overview The polycystic ovarian syndrome market is entering a phase of rapid diagnostic expansion driven by non-invasive diagnostic biomarkers and early screening devices. The Polycystic Ovarian Syndrome Market is projected to grow steadily through 2030, supported by pediatric endocrine screening initiatives, automated multi-hormone diagnostic testing cards, and clinical goals focused on...